| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0043 | 0.9 |